These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 12892048

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms.
    Lohr JB, Cadet JL, Lohr MA, Larson L, Wasli E, Wade L, Hylton R, Vidoni C, Jeste DV, Wyatt RJ.
    Schizophr Bull; 1988; 14(2):291-6. PubMed ID: 2904696
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Buspirone in the treatment of tardive dyskinesia.
    Moss LE, Neppe VM, Drevets WC.
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Vitamin E in the treatment of tardive dyskinesia: a meta-analysis.
    Xu H, Qin H, Chen S, Guan M.
    Int Clin Psychopharmacol; 2022 Mar 01; 37(2):60-66. PubMed ID: 35045531
    [Abstract] [Full Text] [Related]

  • 31. Oxidative mechanisms and tardive dyskinesia.
    Lohr JB, Kuczenski R, Niculescu AB.
    CNS Drugs; 2003 Mar 01; 17(1):47-62. PubMed ID: 12467492
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG.
    Arch Gen Psychiatry; 1997 Jun 01; 54(6):549-57. PubMed ID: 9193196
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G.
    Drug Saf; 1999 Feb 01; 20(2):187-93. PubMed ID: 10082074
    [Abstract] [Full Text] [Related]

  • 37. Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.
    Lerner V, Miodownik C, Kaptsan A, Bersudsky Y, Libov I, Sela BA, Witztum E.
    J Clin Psychiatry; 2007 Nov 01; 68(11):1648-54. PubMed ID: 18052557
    [Abstract] [Full Text] [Related]

  • 38. Benzodiazepines for neuroleptic-induced tardive dyskinesia.
    Bhoopathi PS, Soares-Weiser K.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD000205. PubMed ID: 16855954
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of tardive dyskinesia with lecithin.
    Jackson IV, Nuttall EA, Ibe IO, Perez-Cruet J.
    Am J Psychiatry; 1979 Nov 19; 136(11):1458-60. PubMed ID: 40440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.